Ross L Levine Selected Research

Cytokine Receptors (Cytokine Receptor)

8/2012	Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.
2/2012	Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ross L Levine Research Topics

Disease

104	Neoplasms (Cancer) 05/2024 - 11/2005
56	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 11/2006
32	Leukemia 11/2023 - 10/2006
25	Primary Myelofibrosis (Myelosclerosis) 01/2023 - 04/2005
14	Polycythemia Vera 08/2013 - 04/2005
13	Fibrosis (Cirrhosis) 12/2023 - 06/2006
10	Hematologic Neoplasms (Hematological Malignancy) 10/2023 - 11/2013
9	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2019 - 02/2012
9	Essential Thrombocythemia 08/2013 - 04/2005
8	Thrombocytosis (Thrombocythemia) 05/2013 - 09/2005
8	Myeloproliferative Disorders (Myeloproliferative Disorder) 02/2013 - 08/2005
7	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 08/2005
7	Splenomegaly 10/2021 - 06/2006
5	Glioma (Gliomas) 02/2012 - 12/2006
4	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2022 - 08/2005
4	Lymphoma (Lymphomas) 01/2021 - 12/2018
4	Breast Neoplasms (Breast Cancer) 01/2020 - 02/2014
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2012 - 11/2007
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 03/2016
3	Polycythemia (Erythrocytosis) 10/2021 - 01/2006
3	Hyperplasia 01/2021 - 06/2006
3	Melanoma (Melanoma, Malignant) 01/2021 - 12/2012
3	Atherosclerosis 01/2021 - 05/2013
3	Blast Crisis (Blast Phase) 01/2021 - 12/2018
3	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 12/2019 - 09/2010
3	Carcinogenesis 12/2018 - 09/2013
3	Thrombosis (Thrombus) 10/2013 - 01/2012
3	Stroke (Strokes) 04/2009 - 01/2003
2	Thyroid Neoplasms (Thyroid Cancer) 01/2023 - 11/2018
2	Acute Promyelocytic Leukemia 01/2021 - 10/2013
2	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 12/2006
2	Anemia 03/2017 - 10/2014
2	Hypercholesterolemia 09/2016 - 05/2013
2	Hairy Cell Leukemia 10/2015 - 05/2012
2	Thrombocytopenia (Thrombopenia) 10/2014 - 04/2009
2	Rheumatoid Arthritis 04/2014 - 06/2012
2	Myocardial Infarction 04/2009 - 01/2003
2	Ischemic Stroke 11/2007 - 01/2003
2	Hypersensitivity (Allergy) 07/2006 - 06/2006

Drug/Important Bio-Agent (IBA)

21	Phosphotransferases (Kinase)IBA 11/2023 - 11/2005
18	Janus Kinase InhibitorsIBA 05/2024 - 04/2009
15	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2024 - 04/2005
15	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 08/2005
14	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2023 - 03/2010
13	Proteins (Proteins, Gene)FDA Link 11/2023 - 09/2011
11	CytokinesIBA 01/2023 - 06/2006
10	ruxolitinibIBA 10/2021 - 06/2013
8	alpha-hydroxyglutarateIBA 01/2021 - 03/2010
6	enasidenibIBA 10/2023 - 01/2017
6	Transcription Factors (Transcription Factor)IBA 11/2022 - 10/2013
6	Janus KinasesIBA 03/2016 - 02/2007
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2023 - 05/2014
5	Reticulin (Reticular Fiber)IBA 01/2022 - 06/2006
5	ChromatinIBA 01/2022 - 09/2012
5	CohesinsIBA 01/2021 - 09/2014
5	CholesterolIBA 10/2020 - 02/2013
5	Thrombopoietin ReceptorsIBA 11/2018 - 01/2007
4	Tyrosine (L-Tyrosine)FDA Link 11/2023 - 11/2005
4	Biomarkers (Surrogate Marker)IBA 10/2023 - 04/2009
4	Decitabine FDA Link 01/2023 - 12/2018
4	Janus Kinase 2IBA 01/2020 - 08/2005
4	EnzymesIBA 01/2018 - 03/2010
4	Histones (Histone)IBA 11/2015 - 02/2012
3	Heme (Haem)IBA 10/2023 - 12/2018
3	CollagenIBA 01/2023 - 01/2017
3	AnthracyclinesIBA 01/2023 - 12/2016
3	SphingolipidsIBA 01/2022 - 12/2016
3	CeramidesIBA 10/2019 - 09/2014
3	RNA (Ribonucleic Acid)IBA 12/2018 - 03/2013
3	ErbB Receptors (EGF Receptor)IBA 03/2016 - 12/2006
3	VemurafenibIBA 10/2015 - 12/2012
3	Erythropoietin FDA Link 02/2014 - 06/2006
2	Serine (L-Serine)FDA Link 11/2023 - 05/2012
2	Formaldehyde (Formol)FDA Link 11/2023 - 12/2018
2	Therapeutic UsesIBA 11/2023 - 02/2013
2	Glucose (Dextrose)FDA LinkGeneric 09/2023 - 02/2013
2	IodineIBA 01/2023 - 11/2018
2	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2023 - 03/2016
2	Azacitidine (5 Azacytidine)FDA Link 01/2021 - 01/2017
2	venetoclaxIBA 01/2021 - 10/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 04/2010
2	InflammasomesIBA 01/2021 - 01/2020
2	Lysine (L-Lysine)FDA Link 10/2020 - 11/2015
2	Apolipoproteins E (ApoE)IBA 01/2020 - 08/2012
2	DioxygenasesIBA 01/2020 - 01/2014
2	fedratinibIBA 01/2020 - 04/2008
2	RNA Splicing FactorsIBA 10/2019 - 05/2012
2	Arginine (L-Arginine)FDA Link 01/2019 - 05/2012
2	isocitric acid (isocitrate)IBA 01/2019 - 01/2016
2	CalreticulinIBA 01/2019 - 11/2018
2	Thrombopoietin (c-mpl Ligand)IBA 09/2016 - 07/2006
2	Cytokine Receptors (Cytokine Receptor)IBA 08/2012 - 02/2012
1	Aligeron (AS 2)IBA 03/2024

Therapy/Procedure

56	Therapeutics 10/2023 - 01/2003
9	Drug Therapy (Chemotherapy) 01/2021 - 02/2014
5	Transplantation 01/2020 - 04/2013
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 02/2007 - 01/2006
2	Precision Medicine 01/2021 - 12/2020
2	Radiotherapy 12/2020 - 01/2020
2	Stents 11/2007 - 08/2007